AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

SitaOD M 50mg/1000mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Macleods Pharmaceuticals Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview SitaOD M 50mg/1000mg Tablet SR

The dual-action SitaOD M 50mg/1000mg SR tablet effectively manages elevated blood glucose in individuals with type 2 diabetes. This dual-therapy approach helps mitigate serious diabetic complications, including renal impairment and vision loss, and may lessen the risk of cardiovascular events. SitaOD M 50mg/1000mg SR tablets can be used as monotherapy or in conjunction with other antidiabetic agents. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is tailored to individual needs, considering health status, blood glucose readings, and concurrent medications. Consuming the medication with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes efficacy; discontinuation should only occur under medical supervision. Adherence to the prescribed diet and exercise regimen is crucial for comprehensive diabetes management, as lifestyle significantly impacts blood sugar control. Commonly reported side effects include nausea, vomiting, diarrhea, abdominal discomfort, headache, and pharyngitis. Hypoglycemia, a potential side effect when used with insulin or sulfonylureas, necessitates awareness of its symptoms and management strategies. This medication is not universally suitable. Individuals with pre-existing kidney, liver, or heart disease; pancreatic issues; or significant alcohol consumption should consult their physician before commencing treatment. Similar consultation is recommended for pregnant or lactating women. To ensure safety, inform your doctor of all other medications being taken, as interactions may occur. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Kidney function and blood glucose levels will be monitored regularly by your doctor throughout treatment.

Uses of SitaOD M 50mg/1000mg Tablet SR

Managing type 2 diabetes

Major Benefits of SitaOD M 50mg/1000mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the SitaOD M 50mg/1000mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.

Common Side effects of SitaOD M 50mg/1000mg Tablet SR:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use SitaOD M 50mg/1000mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the SitaOD M 50mg/1000mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.

How SitaOD M 50mg/1000mg Tablet SR works:

SitaOD M 50mg/1000mg extended-release tablets combine sitagliptin and metformin to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action promotes superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining SitaOD M 50mg/1000mg SR tablets with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release SitaOD M 50mg/1000mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release SitaOD M 50mg/1000mg tablet is likely unsuitable for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

The extended-release SitaOD M 50mg/1000mg tablet requires careful administration in individuals with impaired kidney function. Dosage modification may be necessary. Physician consultation is recommended. In cases of severe kidney disease, SitaOD M 50mg/1000mg Tablet SR is contraindicated. Close monitoring of renal function is advised during treatment.

LiverLiverUNSAFE

The extended-release SitaOD M 50mg/1000mg tablet is likely contraindicated for individuals with hepatic impairment and should be omitted. Physician consultation is recommended.

What if you forget to take SitaOD M 50mg/1000mg Tablet SR :

Should you forget a SitaOD M 50mg/1000mg Tablet SR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About SitaOD M 50mg/1000mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on SitaOD M 50mg/1000mg Tablet SR

SitaOD M 50mg/1000mg SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of SitaOD M 50mg/1000mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), and urinary issues, along with cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
SitaOD M 50mg/1000mg Tablet SR may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
SitaOD M 50mg/1000mg Tablet SR is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining SitaOD M 50mg/1000mg Tablet SR with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (SitaOD M 50mg/1000mg SR) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, older adults, and heavy alcohol users. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin/Metformin and seek immediate medical attention.
SitaOD M 50mg/1000mg SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
SitaOD M 50mg/1000mg Tablet SR may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
SitaOD M 50mg/1000mg Tablet SR is contraindicated in patients with known allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining SitaOD M 50mg/1000mg Tablet SR with alcohol is unsafe and may raise the risk of lactic acidosis.
Sitagliptin/Metformin (SitaOD M 50mg/1000mg Tablet SR) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect is a reason to avoid this medication in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Seek immediate medical attention and discontinue Sitagliptin/Metformin if these symptoms occur.
Prolonged use of SitaOD M 50mg/1000mg Tablet SR can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and gait problems), urinary issues, cognitive changes, and balance difficulties. To mitigate this risk, annual supplementation with vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
SitaOD M 50mg/1000mg SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
SitaOD M 50mg/1000mg Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
SitaOD M 50mg/1000mg Tablet SR is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining SitaOD M 50mg/1000mg Tablet SR with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (SitaOD M 50mg/1000mg SR) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin/Metformin immediately and seek medical attention.
Prolonged use of SitaOD M 50mg/1000mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
SitaOD M 50mg/1000mg Tabl...
115
MRP 133
13% off